Head and Neck Cancer Trial, Recruiting (NCT06708754)

Head and Neck Cancer Trial, Recruiting NCT06708754 Sponsor: NYU Langone Health Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06708754 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had radiation treatment for head and neck cancer, and it has been at least 3 months but less than 36 months (3 years) since your last radiation treatment.
You received at least 50Gy (a measure of radiation dose) of radiation to both sides of your neck, either with radiation alone or combined with chemotherapy.
A scan or imaging done 3 months after finishing radiation showed no signs of cancer remaining.
You have been assessed by a doctor and have a certain level of tissue hardening/scarring (called fibrosis, scored at 2 or above on a standard medical scale) in the treated area at the time of joining the trial.
You are willing and able to follow all study procedures and attend visits for the full length of the study.

Who may not be able to join:

You are pregnant, planning to become pregnant, or currently breastfeeding.
You are already taking part in another clinical trial testing a drug or device to prevent or treat lymphedema or fibrosis (tissue hardening) related to radiation.
You are not free to make your own decisions, or are under supervision or legal guardianship.
You are unable to attend scheduled visits due to where you live, your personal circumstances, or your mental health.
You have received light/laser therapy (called photobiomodulation or PBM therapy) for radiation side effects within the past year.
You have a known sensitivity to light (photosensitivity).
You have a condition that weakens your immune system, or you are currently taking medication that suppresses your immune system.
If your BMI (a measure of body weight relative to height) is over 30 and the scarred/hardened areas in your neck cannot be clearly identified by a physical examination, you may be excluded at the doctor's discretion (confirm with trial site).
The trial doctor believes, for any reason, that you may not be able to fully follow the study requirements.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kenneth Hu, NYU Langone Health

Phone: 212-731-5880

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06708754

Sponsor: NYU Langone Health

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: 212-731-5880

More information: https://clinicaltrials.gov/study/NCT06708754

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had radiation treatment for head and neck cancer, and it has been at least 3 months but less than 36 months (3 years) since your last radiation treatment.
You received at least 50Gy (a measure of radiation dose) of radiation to both sides of your neck, either with radiation alone or combined with chemotherapy.
A scan or imaging done 3 months after finishing radiation showed no signs of cancer remaining.
You have been assessed by a doctor and have a certain level of tissue hardening/scarring (called fibrosis, scored at 2 or above on a standard medical scale) in the treated area at the time of joining the trial.
You are willing and able to follow all study procedures and attend visits for the full length of the study.

Who may not be able to join:

You are pregnant, planning to become pregnant, or currently breastfeeding.
You are already taking part in another clinical trial testing a drug or device to prevent or treat lymphedema or fibrosis (tissue hardening) related to radiation.
You are not free to make your own decisions, or are under supervision or legal guardianship.
You are unable to attend scheduled visits due to where you live, your personal circumstances, or your mental health.
You have received light/laser therapy (called photobiomodulation or PBM therapy) for radiation side effects within the past year.
You have a known sensitivity to light (photosensitivity).
You have a condition that weakens your immune system, or you are currently taking medication that suppresses your immune system.
If your BMI (a measure of body weight relative to height) is over 30 and the scarred/hardened areas in your neck cannot be clearly identified by a physical examination, you may be excluded at the doctor's discretion (confirm with trial site).
The trial doctor believes, for any reason, that you may not be able to fully follow the study requirements.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NYU Langone Health

Registry

ClinicalTrials.gov

Start date

13 February 2025

Est. completion

13 February 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Soft tissue thickness (STT) at Nodal Level II - Right Side; STT at Nodal Level II - Left Side; STT at Nodal Level III - Right Side; STT at Nodal Level III - Left Side; STT at Nodal Level IV - Right Side; STT at Nodal Level IV - Left Side

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov